Christoffer V Sørensen, Julián Fernández, Anna Christina Adams, Helen H K Wildenauer, Sanne Schoffelen, Line Ledsgaard, Manuela B Pucca, Michael Fiebig, Felipe A Cerni, Tulika Tulika, Bjørn G Voldborg, Aneesh Karatt-Vellatt, J Preben Morth, Anne Ljungars, Lise M Grav, Bruno Lomonte, Andreas H Laustsen
Improved therapies are needed against snakebite envenoming, which kills and permanently disables thousands of people each year. Recently developed neutralizing monoclonal antibodies against several snake toxins have shown promise in preclinical rodent models. Here, we use phage display technology to discover a human monoclonal antibody and show that this antibody causes antibody-dependent enhancement of toxicity (ADET) of myotoxin II from the venomous pit viper, Bothrops asper, in a mouse model of envenoming that mimics a snakebite...
January 16, 2024: Nature Communications